StrokeNet

StrokeNet
Name	StrokeNet
Formation	2013
Type	Clinical research network
Purpose	Stroke clinical trials coordination
Headquarters	United States
Region served	International (primarily United States)
Parent organization	National Institute of Neurological Disorders and Stroke

StrokeNet

StrokeNet is a clinical trials network established to accelerate research on stroke prevention, acute treatment, and recovery through coordinated multicenter studies, standardized protocols, and centralized training. The network links academic medical centers, community hospitals, and research organizations to support randomized controlled trials, observational studies, and translational research intended to improve outcomes after ischemic stroke, hemorrhagic stroke, and transient ischemic attack. StrokeNet collaborates with federal agencies, professional societies, and patient advocacy groups to foster evidence-based advances in cerebrovascular medicine.

Overview

StrokeNet functions as a national and international research infrastructure that provides regulatory coordination, biostatistics, data management, and site-monitoring for multicenter stroke trials. The network integrates specialty centers such as comprehensive stroke centers and primary stroke centers with community stroke programs to enable rapid enrollment in trials across diverse populations. StrokeNet's activities intersect with major clinical research initiatives and policy frameworks from agencies such as the National Institutes of Health, Food and Drug Administration, and Patient-Centered Outcomes Research Institute. Stakeholders include academic institutions like Johns Hopkins Hospital, Massachusetts General Hospital, and Houston Methodist Hospital, as well as specialty societies including the American Heart Association and the American Stroke Association.

History and Development

StrokeNet was initiated following recognition by the National Institute of Neurological Disorders and Stroke that coordinated multicenter efforts could streamline trial conduct after landmark studies such as the NINDS tPA Trial and the MR CLEAN trial reshaped acute stroke care. The network's development built on prior consortia including the Stroke Prevention Research Unit collaborations and lessons from trials like ECASS and DEFUSE 3. Key milestones include establishment of central Institutional Review Board processes, standardized case report forms influenced by the Common Data Elements initiative, and expansion of regional coordinating centers modeled on networks such as the Clinical and Translational Science Awards consortium. StrokeNet grew in phases, adding regional coordinating centers, performance sites, and training centers to respond to evolving trial needs exemplified by studies of endovascular therapy and neurorehabilitation.

Organizational Structure and Membership

The network's governance features a steering committee, protocol review committee, and data and safety monitoring board, with leadership drawn from academic institutions including University of California, Los Angeles, Duke University, and University of Pennsylvania. Regional coordinating centers manage clusters of performance sites often anchored at tertiary referral centers like Cleveland Clinic and Mount Sinai Hospital. Membership comprises principal investigators, stroke neurologists, emergency physicians, neuroradiologists, rehabilitation specialists, and research coordinators from institutions such as University of Michigan Health System, Stanford Health Care, and Barnes-Jewish Hospital. Collaboration extends to professional organizations like the Society of Vascular and Interventional Neurology and patient advocacy groups such as National Stroke Association.

Research Programs and Clinical Trials

StrokeNet supports a portfolio spanning acute reperfusion trials, secondary prevention, and recovery interventions. Notable trial domains include thrombolytic strategies influenced by the ECASS and NINDS tPA Trial legacy, endovascular device evaluations following MR CLEAN and SWIFT PRIME, anticoagulation and antiplatelet strategies building on WARSS and SPARCL, and rehabilitation approaches informed by research from centers like Kessler Foundation and Rehab Institute of Chicago. StrokeNet also facilitates biomarker discovery linked to efforts at institutions such as Mayo Clinic and Vanderbilt University Medical Center, and leverages imaging cores with expertise from Massachusetts General Hospital and University of California, San Francisco.

Training, Education, and Outreach

Training programs within the network provide coursework and mentored experiences for investigators modeled after career-development mechanisms like the NIH K-series awards and clinical research fellowships at centers such as Brigham and Women's Hospital and Columbia University Irving Medical Center. StrokeNet organizes investigator meetings, simulation workshops, and protocol training similar to programs run by the American Academy of Neurology and the Society for Academic Emergency Medicine. Outreach includes community engagement with survivors and caregivers through partnerships with American Stroke Association chapters and public health campaigns paralleling initiatives by the Centers for Disease Control and Prevention.

Funding and Partnerships

Primary funding derives from the National Institute of Neurological Disorders and Stroke with supplemental grants and cooperative agreements coordinated with the National Institutes of Health and philanthropic contributions from organizations like the American Heart Association and disease-specific foundations. Industry partnerships with device manufacturers and pharmaceutical companies enable trials of endovascular devices and novel therapeutics, governed by contractual agreements and oversight by entities such as the Food and Drug Administration. Collaborative agreements with consortia like the Clinical Trials Network and international partners expand capacity for global trials involving sites linked to institutions such as University College London and Charité – Universitätsmedizin Berlin.

Impact and Outcomes

StrokeNet has contributed to faster trial initiation, more diverse participant enrollment, and improved protocol standardization, accelerating evidence generation for interventions that affect clinical guidelines curated by the American Heart Association and European Stroke Organisation. Outcomes include publications in journals such as The New England Journal of Medicine, Lancet, and Stroke, incorporation of trial findings into guidelines like the AHA/ASA Guidelines for Early Management of Patients with Acute Ischemic Stroke, and enhanced training pipelines producing clinician-investigators at institutions like Yale School of Medicine and University of Toronto. The network has influenced practice patterns in reperfusion therapy, secondary prevention, and rehabilitation, while continuing to address disparities highlighted by research from centers including Johns Hopkins Bloomberg School of Public Health and University of California, San Diego.

Category:Clinical research networks